Ziel
WHO has set a target date for measles eradication in Europe by 2007? Political commitment to achieve and maintain high vaccination coverage and to enhance surveillance to monitor progress is key elements in this strategy. Laboratory confirmation and virus typing is essential for measles surveillance since clinical diagnosis has been shown to be unreliable. Experience in the UK has shown that the use of non-invasive specimens, such as oral fluid, results in high compliance rates. This concerted action aims to define the value of a measles surveillance programme based on oral-fluid testing. The evidence-based data is expected to give a clearer picture of measles in Europe, transmission patterns in Europe, vaccine efficacy and safety. The project will contribute to the QOL programme by improving surveillance (1.1.1-2.3.2) and control of infectious disease (1.1.1-2.2.3)
Wissenschaftliches Gebiet
Programm/Programme
Aufforderung zur Vorschlagseinreichung
Data not availableFinanzierungsplan
CON - Coordination of research actionsKoordinator
NW9 5DF LONDON
Vereinigtes Königreich